The Association of SGLT-2 inhibitors (Empagliflozin) with the development of hypernatremic dehydration: a case report
Sodium-Glucose-Cotransporter -2 inhibitors (SGLT2 inhibitors) are a new class of drugs that reduce blood glucose levels by increasing glucose excretion and lowering blood pressure through natriuresis and plasma volumen contraction. Due to their beneficial effects, they are currently used in treatmen...
Saved in:
Main Authors: | Diana Alegre-González, Sandra García-Guerreros, Sara Martínez-Hernández, Ana Yasmina Brito-Díaz, Marta Casañas-Martínez, Ramón Baeza-Trinidad |
---|---|
Format: | Article |
Language: | English |
Published: |
Emergency Department of Hospital San Pedro (Logroño, Spain)
2025-10-01
|
Series: | Iberoamerican Journal of Medicine |
Subjects: | |
Online Access: | https://doi.org/10.53986/ibjm.2025.0001 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Sodium glucose co-transporter 2 inhibitors (SGLT2i) for pediatric kidney disease: the future is near
by: Gilda M. Portalatin, et al.
Published: (2025-01-01) -
Research Progress of SGLT2 Inhibitors in Cancer Treatment
by: Miao X, et al.
Published: (2025-01-01) -
Preliminary Study: Expulsive Effect of Empagliflozin on Small Lower Ureteric Stones in Type II Diabetic Patients
by: Alsayed S. Abdelaziz, et al.
Published: (2024-01-01) -
Physiology of wrestlers` dehydration
by: Asim Cengız, et al.
Published: (2013-08-01) -
A study on the pharmacovigilance of various SGLT-2 inhibitors
by: Yanwen Dong, et al.
Published: (2025-01-01)